Live Breaking News & Updates on News Ratings For Reneo Pharmaceuticals Daily

Stay updated with breaking news from News ratings for reneo pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Consensus Rating of "Reduce" from Analysts

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report) has received an average recommendation of “Reduce” from the eight research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and seven have issued a hold recommendation on the company. The average 1 year target […] ....

Braden Michael Leonard , Capital Management , Securities Exchange Commission , Reneo Pharmaceuticals Stock Performance , Reneo Pharmaceuticals , Highbridge Capital Management , Eventide Asset Management , News Ratings For Reneo Pharmaceuticals Daily , Analyst Recommendations For Reneo Pharmaceuticals , Marquette Asset Management , Reneo Pharmaceuticals Inc , Reneo Pharmaceuticals Company Profile , Get Free Report , Exchange Commission , Point Capital , Asset Management , Get Free , Reneo Pharmaceuticals Daily ,

HC Wainwright Reaffirms "Neutral" Rating for Reneo Pharmaceuticals (NASDAQ:RPHM)

HC Wainwright reaffirmed their neutral rating on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $1.50 target price on the stock. Reneo Pharmaceuticals Trading Up 5.4 % Shares of RPHM stock opened at $1.75 on Tuesday. The stock has a […] ....

Braden Michael Leonard , News Ratings For Reneo Pharmaceuticals Daily , Reneo Pharmaceuticals Trading , Reneo Pharmaceuticals Inc , Reneo Pharmaceuticals Company Profile , Reneo Pharmaceuticals , Analyst Recommendations For Reneo Pharmaceuticals , Marquette Asset Management , Capital Management , Eventide Asset Management , Highbridge Capital Management , Free Report , Get Free Report , Point Capital , Asset Management , Reneo Pharmaceuticals Daily ,

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 414,281 Shares of Stock

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 414,281 Shares of Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Braden Michael Leonard , News Ratings For Reneo Pharmaceuticals Daily , Reneo Pharmaceuticals Price Performance , Reneo Pharmaceuticals , Eventide Asset Management , Reneo Pharmaceuticals Inc , Securities Exchange Commission , Sg Americas Securities , Capital Management , Get Free Report , Exchange Commission , Asset Management , Capital Partners , Pale Fire Capital , Reneo Pharmaceuticals Daily ,

Reneo Pharmaceuticals (NASDAQ:RPHM) Stock Price Up 0.6%

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report)’s stock price traded up 0.6% on Tuesday . The company traded as high as $1.71 and last traded at $1.71. 86,279 shares were traded during trading, a decline of 73% from the average session volume of 318,690 shares. The stock had previously closed at $1.70. Analyst Upgrades […] ....

United States , Piper Sandler , Goldman Sachs Group Inc , Capital Management , Hedge Funds Weigh In On Reneo Pharmaceuticals , Reneo Pharmaceuticals Inc , Jefferies Financial Group , Reneo Pharmaceuticals Stock , Reneo Pharmaceuticals , Capital Partners , Reneo Pharmaceuticals Company Profile , News Ratings For Reneo Pharmaceuticals Daily , Get Free Report , Sachs Group , Fire Capital , Vestal Point Capital , Reneo Pharmaceuticals Daily , Nasdaq Rphm ,

Pale Fire Capital SE Makes New Investment in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)

Pale Fire Capital SE purchased a new stake in shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 14,851 shares of the company’s stock, valued at approximately $113,000. A number of other institutional investors have also […] ....

United States , Robertw Baird , York Mellon Corp , News Ratings For Reneo Pharmaceuticals Daily , Barclays Plc , Wells Fargo Company , Reneo Pharmaceuticals Inc , Reneo Pharmaceuticals Company Profile , Dorsey Wright Associates , Reneo Pharmaceuticals Stock Performance , Reneo Pharmaceuticals , Quarter For Reneo Pharmaceuticals , Pale Fire Capital , Free Report , New York Mellon Corp , Wells Fargo , Reneo Pharmaceuticals Daily , Nasdaq Rphm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,